PAPL Inhibitors
PAPL inhibitors are a class of chemical compounds designed to target and inhibit the enzyme known as poly(A)-specific ribonuclease-like domain-containing protein (PAPL). PAPL is involved in RNA metabolism, specifically in the degradation of polyadenylated RNA. This enzyme plays a crucial role in the process of deadenylation, which is the shortening and removal of the poly(A) tail from mRNA molecules. Deadenylation is an essential step in mRNA turnover, as it marks the beginning of mRNA decay, leading to the eventual degradation of mRNA and the regulation of gene expression. By inhibiting PAPL, these compounds disrupt the deadenylation process, thereby affecting mRNA stability and the overall dynamics of RNA metabolism in cells.
PAPL inhibitors work by binding to the enzyme's active site or interfering with its ability to catalyze the removal of poly(A) tails from RNA. This inhibition alters the normal degradation pathway of mRNA, providing valuable insights into the role of PAPL in RNA turnover and stability. Researchers use these inhibitors to study how PAPL contributes to regulating the life cycle of mRNA and its impact on gene expression. PAPL inhibitors are useful tools for understanding the broader processes involved in RNA metabolism, including mRNA surveillance, decay, and the coordination of RNA degradation with cellular responses. By exploring the inhibition of PAPL, scientists can uncover important mechanisms that control mRNA fate and the regulation of protein synthesis, highlighting the enzyme's critical role in maintaining cellular RNA homeostasis.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide obstructs the elongation step of protein synthesis on ribosomes, potentially decreasing the synthesis rate of proteins like PAPL. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
This compound binds to the DNA template at the transcription initiation complex, halting the elongation of RNA chains, thereby reducing the synthesis of PAPL mRNA. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
By specifically inhibiting the mTOR pathway, Rapamycin can lead to reduced translation rates of proteins, potentially diminishing PAPL protein levels. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase inhibitor, Trichostatin A removes acetyl groups from histones, leading to tighter DNA winding and decreased transcription of genes including that of PAPL. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine incorporates into DNA, disrupts methylation patterns, and results in the reduction of gene expression, potentially leading to lower PAPL levels. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
By inhibiting the proteasome, MG-132 causes accumulation of misfolded proteins, inducing cellular stress responses that can downregulate protein production including PAPL. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine disrupts lysosomal acidification and DNA/RNA synthesis, which can result in decreased transcription and subsequent lower levels of PAPL. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine selectively inhibits specific cyclin-dependent kinases, leading to cell cycle arrest and a consequent decrease in the transcription of cycle-regulated genes, including possibly PAPL. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
This compound reduces guanine synthesis by inhibiting inosine monophosphate dehydrogenase, leading to decreased proliferation and potentially lower expression levels of proteins such as PAPL. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid binds to its nuclear receptors which then hinder the transcription of certain genes, potentially resulting in the decreased expression of PAPL. | ||||||